Refractory Angina: Clinical Trials

19 trials for Refractory Angina, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 5 recruiting, 3 unknown, 2 active not recruiting. 11 Not applicable, 8 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable11Completed 4, Recruiting 3, Active not recruiting 2, Unknown 2
Phase 28Completed 3, Recruiting 2, Suspended 1, Unknown 1, Withdrawn 1
Phase 11Completed 1
Phase 31Unknown 1

Follow Refractory Angina: new trials by email Literature Review of Refractory Angina trials Research Report on Refractory Angina

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
XC001, Sham (No Treatment) - Refractory Angina, Coronary Artery Disease
Phase 2RecruitingXyloCor Therapeutics, Inc.1062025-07-082026-09-11
Wave Crossover ECP Study for Simplified Therapy
External Counterpulsation - Chronic Stable Angina, Refractory Angina
Not applicableCompletedPression522024-09-262026-04-07
Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina
Bone marrow aspiration and a single intracoronary infusion of autologous bone marrow-derived mononuclear cells., Sham bone marrow aspiration and sham cell infusion (insertion of vascular access sheath). - Refractory Angina Pectoris, Refractory Angina
Phase 2RecruitingBarts & The London NHS Trust1102024-03-012026-01-07
Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction.
Coronary sinus reducer, Sham Procedure, Invasive coronary physiology - Refractory Angina, Microvascular Angina
Not applicableActive not recruitingImperial College London542023-04-172026-08-17
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Arm 1: treatment with Shockwave Reducer, Arm 2 (control): Implantation procedure with no device implanted, Arm 3 (unblinded, non-randomized): Single arm registry - Refractory Angina
Not applicableRecruitingShockwave Medical, Inc.3802022-01-042026-09-30
CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial
CardiAMP Cell Therapy System, Sham Treatment - Refractory Angina, Chronic Myocardial Ischemia
Not applicableActive not recruitingBioCardia, Inc.3432021-06-302026-01-06
Coronary Sinus Reducer Objective Impact on Symptoms, MRI Ischaemia and Microvascular Resistance
Coronary Sinus Reducer, Placebo Procedure - Refractory Angina
Not applicableUnknownImperial College London502021-05-212023-10-30
COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina
Coronary sinus reducer, Optimal medical therapy - Coronary Microvascular Disease, Refractory Angina
Not applicableRecruitingJohannes Gutenberg University Mainz1442021-04-012023-09-28
Allopurinol in Patients With Refractory Angina to Improve Ischemic Symptoms
Allopurinol 300 MG, Placebo oral tablet - Refractory Angina
Phase 2 / Phase 3UnknownMinistry of Health, Brazil402021-03-032021-02-24
A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory Angina
IMB-1018972, Placebo oral tablet - Refractory Angina
Phase 2WithdrawnImbria Pharmaceuticals, Inc.2020-05-012025-11-10
HARapan kiTa ECP (External Counter Pulsation) Study HARTEC Study
External Counter Pulsation (ECP) therapy - Cardiac Rehabilitation, Angiogenesis
Not applicableUnknownNational Cardiovascular Center Harapan Kita Hospital Indonesia502019-07-012020-06-16
Cardiac Rehabilitation in Patients With Refractory Angina
Cardiac Rehabilitation - Refractory Angina
Not applicableCompletedHospital Israelita Albert Einstein722016-01-012022-02-11
Coronary Arteriogenetic Heparinized Exercise
Physical rehabilitation, Heparin, Placebo - Refractory Angina, Chronic Stable Angina
Not applicableCompletedClinical Centre of Serbia322013-02-012020-05-13
Lipoprotein Apheresis in Refractory Angina Study
Lipoprotein Apheresis, Sham Apheresis - Refractory Angina, Raised Lipoprotein(a)>50mg/dL or >500mg/L
Not applicableCompletedImperial College London202013-02-012019-11-12
Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization
Neovac coronary sinus reducer - Refractory Angina
Not applicableRecruitingTel-Aviv Sourasky Medical Center1002011-08-302022-02-02
Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA
Neovasc Reducer, Control - Refractory Angina
Phase 2CompletedShockwave Medical, Inc.1042010-09-012013-11-25
Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis
Selected CD 133+ cells - Coronary Artery Disease, Refractory Angina
Phase 1 / Phase 2CompletedPilar Jimenez Quevedo282008-05-012013-08-06
Intramyocardial Delivery of Autologous Bone Marrow
Mononuclear bone marrow derived cells - Refractory Angina
Phase 2SuspendedIRCCS San Raffaele132007-05-012012-02-02
Study Protocol of Intramyocardial Injection of Autologous Bone Marrow Stem Cells for Refractory Angina
Local sedation, Bone Marrow Aspiration, Minithoracotomy - Refractory Angina
Phase 2CompletedCellPraxis Bioengenharia Ltda.132005-07-012014-06-03

Narrower conditions

Angina Pectoris (19)  ·  Coronary Artery Disease (4)  ·  Angina, Stable (2)  ·  Microvascular Angina (2)  ·  Chest Pain (1)  ·  Coronary Disease (1)  ·  Myocardial Ischemia (1)

Broader conditions

Cardiovascular Diseases (19)  ·  Heart Diseases (19)  ·  Neurologic Manifestations (19)  ·  Pain (19)  ·  Pathological Conditions, Signs and Symptoms (19)  ·  Signs and Symptoms (19)  ·  Vascular Diseases (19)  ·  Chest Pain (18)  ·  Myocardial Ischemia (18)  ·  Arterial Occlusive Diseases (4)  ·  Arteriosclerosis (4)  ·  Coronary Disease (3)

Interventions

Allopurinol (1)  ·  Cardiac Rehabilitation (1)  ·  Counterpulsation (1)  ·  Heparin (1)  ·  Protons (1)  ·  Therapeutics (1)  ·  salicylhydroxamic acid (1)

Sponsors

Imperial College London (3)  ·  Shockwave Medical, Inc. (2)  ·  Barts & The London NHS Trust (1)  ·  BioCardia, Inc. (1)  ·  CellPraxis Bioengenharia Ltda. (1)  ·  Clinical Centre of Serbia (1)  ·  Hospital Israelita Albert Einstein (1)  ·  IRCCS San Raffaele (1)  ·  Imbria Pharmaceuticals, Inc. (1)  ·  Johannes Gutenberg University Mainz (1)  ·  Ministry of Health, Brazil (1)  ·  National Cardiovascular Center Harapan Kita Hospital Indonesia (1)  ·  Pilar Jimenez Quevedo (1)  ·  Pression (1)  ·  Tel-Aviv Sourasky Medical Center (1)

Countries

United Kingdom (6)  ·  United States (5)  ·  Brazil (3)  ·  Canada (2)  ·  Belgium (1)  ·  Denmark (1)  ·  Germany (1)  ·  Indonesia (1)  ·  Israel (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Serbia (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Adam Salamon (1)  ·  Ade Meidian Ambari, MD,FIHA (1)  ·  Amish Raval, MD (1)  ·  Ana Djordjevic-Dikic, MD, PhD (1)  ·  Anthony Mathur (1)  ·  Branko Beleslin, MD, PhD (1)  ·  Dudley Pennell, MB BChir MA MD FRCP (1)  ·  Enio Buffolo, MD, PhD (1)  ·  Eugenio Picano, MD, PhD (1)  ·  Gregg W Stone, MD (1)  ·  Luciana Janot de Matos, Dra (1)  ·  Luis Henrique W Gowdak, MD, PhD (1)  ·  Mahmoud Barbir, MB BCh, FRCP (1)  ·  Nelson A Hossne Junior, MD, PhD (1)  ·  Paul Chamberlin, MD (1)

Results publications

PMID 11897431, PMID 16990385, PMID 18404725, PMID 23413981, PMID 24366073, PMID 25651246, PMID 28453721, PMID 32719097, PMID 34760951, PMID 35134662, PMID 38214677, PMID 38395338, PMID 38604209, PMID 38862073, PMID 39668004

NIH funding

2014 (1), 2018 (1)